Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.141.11.4171PMID 11089550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule.

  1999cited by this paper
• Thyroglobulin Type-1 Domains in Equistatin Inhibit Both Papain-like Cysteine Proteinases and Cathepsin D*

  1999cited by this paper
• Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.

  1999cited by this paper
• The insulin-like growth factor-binding protein (IGFBP) superfamily.

  1999cited by this paper
• The insulin-like growth factor binding protein superfamily: new perspectives.

  1999cited by this paper
• Insulin‐like growth factor binding proteins: a proposed superfamily

  1999cited by this paper
• Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid.

  1998cited by this paper
• Isolation and characterization of circulating 13‐kDa C‐terminal fragments of human insulin‐like growth factor binding protein‐5

  1998cited by this paper
• An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.

  1998cited by this paper
• Insulin‐like growth factor (IGF)–binding protein‐3 (IGFBP‐3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor

  1998cited by this paper
• Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily.

  1998cited by this paper
• Recommendations for nomenclature of the insulin-like growth factor binding protein (IGFBP) superfamily.

  1998cited by this paper
• Structure-Function Analysis of the Human Insulin-like Growth Factor Binding Protein-4*

  1998cited by this paper
• Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine.

  1998cited by this paper
• The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.

  1998cited by this paper
• Structural Determinants of Ligand and Cell Surface Binding of Insulin-like Growth Factor-binding Protein-3*

  1998cited by this paper
• Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies.

  1997cited by this paper
• Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins*

  1997cited by this paper
• Characterization of truncated insulin-like growth factor-binding protein-2 in human milk.

  1997cited by this paper
• The Type V Transforming Growth Factor β Receptor Is the Putative Insulin-like Growth Factor-binding Protein 3 Receptor*

  1997cited by this paper
• Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3.

  1997cited by this paper
• Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.

  1997cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*

  1997cited by this paper
• Domain Interplay in the Urokinase Receptor REQUIREMENT FOR THE THIRD DOMAIN IN HIGH AFFINITY LIGAND BINDING AND DEMONSTRATION OF LIGAND CONTACT SITES IN DISTINCT RECEPTOR DOMAINS*

  1996cited by this paper
• A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.

  1996cited by this paper
• IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments.

  1996cited by this paper
• Characterization of Glycosaminoglycan-binding Domains Present in Insulin-like Growth Factor-binding Protein-3*

  1996cited by this paper
• Domain Interplay in the Urokinase Receptor

  1996cited by this paper
• Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7

  1996cited by this paper
• The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action.

  1996cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth.

  1995cited by this paper
• Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4

  1995cited by this paper
• Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity.

  1995cited by this paper
• The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.

  1995cited by this paper
• Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line.

  1994cited by this paper
• Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.

  1994cited by this paper
• Insulin-Like Growth Factor Binding Protein-3 Concentrations and Insulin-Like Growth Factor Binding Protein-3 Protease Activity in Sera of Patients with Malignant Solid Tumors or Leukemia

  1994cited by this paper
• Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells.

  1993cited by this paper
• Transfection of the human IGFBP-3 gene into Balb/c fibroblasts: a model for the cellular functions of IGFBPs.

  1993cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper
• Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream.

  1993cited by this paper
• Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells.

  1993cited by this paper
• The cytoskeletal protein talin contains at least two distinct vinculin binding domains

  1993cited by this paper
• Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action.

  1992cited by this paper
• Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

  1992cited by this paper
• Isolation and characterization of a cDNA encoding the low molecular weight insulin‐like growth factor binding protein (IBP‐1).

  1988cited by this paper
• Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors.

  1988cited by this paper
• Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

  1986cited by this paper

• Association of IGF-1 and IGFBP-3 with metabolic abnormalities among children and adolescents

  2025cites this paper
• The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment

  2024cites this paper
• Response to Different Oxygen Partial Pressures and Evolution Analysis of Apoptosis-Related Genes in Plateau Zokor (Myospalax baileyi)

  2022cites this paper
• IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer

  2020cites this paper
• IGF-I and IGFBP-3 levels and their correlations with carcinoembryonic antigen in colorectal cancer patients

  2018influential citation
• IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.

  2015cites this paper
• Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

  2014cites this paper
• A substrate-optimized electrophoretic mobility shift assay for ADAM12.

  2014cites this paper
• Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?

  2013cites this paper
• Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls

  2012cites this paper
• Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease

  2010cites this paper
• Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review

  2009cites this paper
• Cellular uptake of neutral phosphorodiamidate morpholino oligomers.

  2009cites this paper
• Unraveling insulin-like growth factor binding protein-3 actions in human disease.

  2009cites this paper
• Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study

  2008cites this paper
• IGFBP-3 mediates the effect of tumor suppressor NKX3.1 on prostate cancer cell proliferation

  2008cites this paper
• Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro.

  2006cites this paper
• Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma

  2006cites this paper
• Endocrine control of body composition in infancy, childhood, and puberty.

  2005cites this paper
• XIAP as target for therapeutic apoptosis in prostate cancer.

  2004cites this paper
• Role of N- and C-terminal Residues of Insulin-like Growth Factor (IGF)-binding Protein-3 in Regulating IGF Complex Formation and Receptor Activation*

  2004cites this paper
• What's new in the IGF-binding proteins?

  2004influential citation
• Response of the somatotropic axis of juvenile coho salmon to alterations in plane of nutrition with an analysis of the relationships among growth rate and circulating IGF-I and 41 kDa IGFBP.

  2004cites this paper
• Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.

  2003cites this paper
• A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity

  2003cites this paper
• Cloning, Expression, Characterization, and Role in Autocrine Cell Growth of Cell Surface Retention Sequence Binding Protein-1*

  2003cites this paper
• Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions.

  2003cites this paper
• Role of insulin‐like growth factor binding protein‐3 in breast cancer cell growth

  2002cites this paper
• Prostate cancer: status of current treatments and emerging antisense-based therapies.

  2002cites this paper
• Insulin‐like growth factor binding protein‐3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo

  2002cites this paper
• Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.

  2002cites this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cites this paper
• Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.

  2001cites this paper
• Alterations of the insulin-like growth factor system in patients with polycythemia vera.

  2001cites this paper
• Insulin‐like growth factor (IGF) binding protein‐3 regulation of IGF‐I is altered in an acidic extracellular environment

  2001cites this paper
• Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding.

  2001cites this paper